REMOGLIFLOZIN ETABONATE+METFORMIN
About REMOGLIFLOZIN ETABONATE+METFORMIN
REMOGLIFLOZIN ETABONATE+METFORMIN belongs to the group of anti-diabetic medicines used to treat type-2 diabetes mellitus adjunct to diet and exercise. Type-2 diabetes mellitus is also known as non-insulin-dependent diabetes or adult-onset diabetes. It is a medical condition in which blood glucose levels are above normal due to insulin deficiency, insulin resistance, or both.
REMOGLIFLOZIN ETABONATE+METFORMIN is a combination of two drugs, namely: Remogliflozin etabonate and Metformin. Remogliflozin etabonate helps in removing excess sugar from the body via urine. Metformin works by reducing the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the body’s sensitivity to insulin. Together, REMOGLIFLOZIN ETABONATE+METFORMIN helps control blood sugar levels.
You are advised to take REMOGLIFLOZIN ETABONATE+METFORMIN for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side-effects such as stomach upset, hypoglycaemia, nausea, and vomiting. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to consult your doctor if you experience these side effects persistently.
Consult your doctor if you are pregnant or breastfeeding. Avoid alcohol consumption while taking REMOGLIFLOZIN ETABONATE+METFORMIN as it might cause unpleasant side-effects. Limited information is available regarding the usage of REMOGLIFLOZIN ETABONATE+METFORMIN in children, so please consult a doctor if you have any concerns. Inform your doctor about all the medicines you are taking and your health condition to rule out any unpleasant side effects/interactions.
Uses of REMOGLIFLOZIN ETABONATE+METFORMIN
Medicinal Benefits
REMOGLIFLOZIN ETABONATE+METFORMIN is a combination of two anti-diabetic drugs, namely: Remogliflozin etabonate and Metformin. REMOGLIFLOZIN ETABONATE+METFORMIN is used to treat type-2 diabetes mellitus. Remogliflozin etabonate helps in removing excess sugar from the body via urine. Metformin works by reducing the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the body’s sensitivity to insulin. Together, REMOGLIFLOZIN ETABONATE+METFORMIN helps control blood sugar levels.
Directions for Use
Storage
Side Effects of REMOGLIFLOZIN ETABONATE+METFORMIN
- Stomach upset
- Hypoglycaemia (low blood sugar levels)
- Nausea
- Vomiting
Patients Concern
Disease/Condition Glossary
Type-2 diabetes mellitus: It is also known as non-insulin-dependent diabetes. It is a chronic or lifelong disease that keeps the body from utilizing insulin properly. Diabetes is a medical condition in which blood glucose levels are above normal. People with type 2 diabetes either do not produce enough insulin, or the insulin produced cannot perform its function in the body (insulin resistance). Middle-aged or older individuals are most likely to suffer from type 2 diabetes; hence it is also known as adult-onset diabetes. Type 2 diabetes symptoms include lack of energy, tiredness, frequent urination, excess thirst, dry mouth, blurry vision, constant hunger, weight loss, and itchy skin.
FAQs
REMOGLIFLOZIN ETABONATE+METFORMIN contains Remogliflozin etabonate and Metformin. Remogliflozin etabonate helps in removing excess sugar from the body via urine. Metformin reduces sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the body’s sensitivity to insulin. Together, REMOGLIFLOZIN ETABONATE+METFORMIN helps control blood sugar levels.
Do not stop taking REMOGLIFLOZIN ETABONATE+METFORMIN without consulting your doctor, as it may cause an increase in blood glucose levels. Continue taking REMOGLIFLOZIN ETABONATE+METFORMIN for as long as your doctor has prescribed it to you. Do not be reluctant to speak with your doctor if you experience any difficulty while taking REMOGLIFLOZIN ETABONATE+METFORMIN.
Hypoglycaemia/low blood sugar levels could be the side effect of REMOGLIFLOZIN ETABONATE+METFORMIN. Hypoglycaemia generally occurs when REMOGLIFLOZIN ETABONATE+METFORMIN is taken along with other antidiabetic medicines, without food or with alcohol. Consume sugary food such as candy or fruit juice if you experience hypoglycaemic symptoms such as dizziness, cold sweats, anxiety, or tremor. Regularly monitor blood glucose levels while taking REMOGLIFLOZIN ETABONATE+METFORMIN.
If you miss a dose, try to take it as soon as you remember. However, if it is almost time for the scheduled dose, skip the missed dose and take the scheduled dose instead. Avoid taking the double dose as it might cause unpleasant side effects or overdose.
Low fibre, high fat diet, sugary diet, obesity, smoking, stress, lack of exercise, age, genetic factors, and certain medical conditions are the common causes of diabetes.
